Company: HCWB
Filing Date: 2025-04-16
Form Type: 424B3
Source: 0001193125-25-082835
Chunk: 11

Company: HCW Biologics Inc.
Filing Date: 2025-04-16
Form: 424B3
Chunk 11
---
 value of our Common Stock held by
non-affiliates exceeds $250 million as of the prior June 30, or (ii) our annual revenues exceeded $100 million during such completed fiscal year and the market value of our Common Stock
held by non-affiliates exceeds $700 million as of the prior June 30.

Corporate Information

Our principal executive office is located at 2929 N Commerce Parkway, Miramar, FL 33025, and our telephone number is (954) 842-2024. Our website address is www.hcwbiologics.com. Information on or accessed through our website is not incorporated into and not part of this prospectus.

6

OFFERING SUMMARY This prospectus relates to the resale by selling stockholders consisting of: (1) up to an aggregate of $20,000,000 of shares of our Common Stock, plus, at HCWB’s option upon utilizing the initial $20,000,000, an additional amount equal to the lesser of 100% of the Company’s market capitalization at the time of exercise of such option or $20,000,000, over the 36-monthterm of the ELOC Purchase Agreement, issuable pursuant to the ELOC Purchase Agreement and 384,615 Commitment Shares issued under the ELOC Purchase Agreement and (2) up to an aggregate of 6,717,000 shares of Common Stock issuable upon exercise of the Purchase Warrant.

| Issuer –Issuance of Common Stock                                     |     |                                                                                                                                                                                                                                   HCW Biologics Inc. |
| Shares of Common Stock to be Issued by Us                            |     |                                                                                                                                                    Up to $40,000,000 shares of our Common Stock, which may be issued pursuant to the ELOC Agreement. 
                                                                                                                                                                                  384,615 Commitment Shares issued under the ELOC Purchase Agreement. 
                                                                                                                                                    Up to 6,717,000 shares of our Common Stock, which may be issued pursuant to the Purchase Warrant. |
| Shares of Common Stock outstanding as of the date of this prospectus |     |                                                                                                                                                                                                                                           44,934,120 |
| Resale of Common Stock                                               |     |                                                                                                                                                                                                                                                      |
| Shares of Common Stock Offered by the Selling Stockholders           |     |              Up to $40,000,000 in shares of our Common Stock that may be issued to Square Gate under the ELOC Purchase Agreement, plus up to a total of 7,101,615 shares of our Common Stock